Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 2Sexuality 1Sexual Dysfunction, Physiological 1Infertility 1Cognitive/Functional Effects 1Breast Neoplasms, Male 1Brain Neoplasms 1

Interventions

exemestane 2Tamoxifen 2Letrozole 2Immunotherapy 2Anastrozole 2ribociclib 1elacestrant 1acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 1abemaciclib 1Taxes 1Standard of Care 1Radiosurgery 1Psychiatric Rehabilitation 1Practice Guidelines as Topic 1Neoadjuvant Therapy 1Methods 1Mental Status and Dementia Tests 1Leuprolide 1Interviews as Topic 1Goserelin 1Genetic Testing 1Genetic Counseling 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms, Male × Psychiatric Rehabilitation × 90 days × Clear all
NCT00609791 2026-06-04

Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients of Different Ages With Metastatic Breast Cancer

City of Hope Medical Center

Phase 2 Active not recruiting
40 enrolled 16 charts
Breast

Breast Neoplasms, Breast Neoplasms, Male

Data powered by HemOnc (CC BY 4.0) Colophon âš¡